Tag results:
macrophages
Immune Regulation News
Cyclin J-CDK Complexes Limit Innate Immune Responses by Reducing Proinflammatory Changes in Macrophage Metabolism
[Science Signaling] Scientists demonstrated that cyclin J, a TLR-inducible member of the cyclin family, reduced cytokine production in macrophages by coordinately controlling glycolysis and mitochondrial functions.
Cancer Stem Cell News
A Positive Feedback Loop: RAD18-YAP-TGF-β between Triple-Negative Breast Cancer and Macrophages Regulates Cancer Stemness and Progression
[Cell Death Discovery] TGF-β from tumor-associated macrophages activated RAD18 in triple-negative breast cancer to enhance tumor stemness, forming a positive feedback loop. Inhibition of YAP or TGF-β broke this loop and suppressed cancer stemness and proliferation.
Neural Cell News
Suppression of the Hyaluronic Acid Pathway Induces M1 Macrophages Polarization via STAT1 in Glioblastoma
[Cell Death Discovery] Scientists observed that disrupting glioblastoma hyaluronic acid synthesis or blocking HA binding to its receptor CD44 on macrophages increased the proportion of M1 macrophages by upregulating SIRPα in macrophages,
Neural Cell News
Microglia/Macrophage-Derived Human CCL18 Promotes Glioma Progression via CCR8-ACP5 Axis Analyzed in Humanized Slice Model
[Cell Reports] The authors studied the importance of CCL18, a cytokine expressed in human but not in rodent glioma-associated microglia/macrophages, as a modulator of glioma growth.
Immune Regulation News
Ubiquitin-Like Protein 3 (UBL3) Is Required for MARCH Ubiquitination of Major Histocompatibility Complex Class II and CD86
[Nature Communications] Researchers showed, using a genome-wide CRISPR knockout screen, that UBL3 was a necessary component of ubiquitination-mediated trafficking of major histocompatibility complex class II and CD86 in mice and in humans.
Immune Regulation News
Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis
[Circulation Research] Genetic deletion of pyruvate kinase muscle 2 (PKM2) in myeloid cells or limiting its nuclear translocation reduced atherosclerosis by suppressing inflammation and enhancing efferocytosis.